Published in N Engl J Med on May 30, 1985
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest (2004) 2.24
(Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation. Clin Exp Pharmacol Physiol (2009) 1.83
The collecting duct is the major source of prorenin in diabetes. Hypertension (2008) 1.78
Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol (1996) 1.74
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes (2008) 1.57
Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J Am Soc Nephrol (2009) 1.41
New pharmacological treatments for improving renal outcomes in diabetes. Nat Rev Nephrol (2010) 1.29
(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes (2009) 1.24
A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther (2009) 1.19
The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol (2008) 1.19
Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression. Endocrinology (2009) 1.17
Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge. Rev Endocr Metab Disord (2008) 1.16
Podocytopathy in diabetes: a metabolic and endocrine disorder. Am J Kidney Dis (2011) 1.10
New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev (2012) 0.98
Direct renin inhibition and the kidney. Nat Rev Nephrol (2009) 0.94
Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells. Am J Physiol Endocrinol Metab (2008) 0.93
Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease. Clin Exp Nephrol (2013) 0.92
Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra. Brain Struct Funct (2012) 0.92
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. Vasc Health Risk Manag (2008) 0.90
Roles of the (pro)renin receptor in the kidney. World J Nephrol (2014) 0.89
Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra. Aging Dis (2011) 0.88
Increased expression of (pro)renin receptor does not cause hypertension or cardiac and renal fibrosis in mice. Lab Invest (2014) 0.87
Receptor-mediated nonproteolytic activation of prorenin and induction of TGF-β1 and PAI-1 expression in renal mesangial cells. Am J Physiol Renal Physiol (2012) 0.86
Identification of an enzyme in human kidney that correctly processes prorenin. Proc Natl Acad Sci U S A (1990) 0.85
Recent advances in tissue (pro)renin imaging. Front Biosci (Elite Ed) (2010) 0.85
Prorenin and the (pro)renin receptor in ocular pathology. Am J Pathol (2008) 0.85
Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis (2015) 0.84
Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease. Am J Neurodegener Dis (2012) 0.83
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy. Vasc Health Risk Manag (2008) 0.82
Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM. Br J Ophthalmol (1998) 0.81
The (pro)renin receptor. A decade of research: what have we learned? Pflugers Arch (2012) 0.81
(Pro)renin receptor: a treatment target for diabetic retinopathy? Diabetes (2009) 0.80
Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease. Physiol Rep (2015) 0.79
Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats. PLoS One (2014) 0.78
The pathogenesis and prevention of diabetic glomerulopathy. West J Med (1986) 0.78
Prorenin anno 2008. J Mol Med (Berl) (2008) 0.78
Pancreas transplantation--registry report and a commentary. West J Med (1985) 0.77
Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients? J Hypertens (2011) 0.77
Renin inhibitors in diabetes and hypertension: an update. EXCLI J (2014) 0.75
Direct renin inhibition in chronic kidney disease. Br J Clin Pharmacol (2013) 0.75
Higher plasma prorenin concentration plays a role in the development of coronary artery disease. Biomark Res (2015) 0.75
Aliskiren improves vascular smooth muscle function in the skin microcirculation of type 2 diabetic patients with normal renal function. J Renin Angiotensin Aldosterone Syst (2013) 0.75
Possible contribution of (pro)renin receptor to development of gestational diabetes mellitus. World J Diabetes (2014) 0.75
Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay. Br J Ophthalmol (2005) 0.75
Raised plasma renin and prorenin in rheumatoid vasculitis. Ann Rheum Dis (1990) 0.75
CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). XI. THE TREATMENT OF ACUTE MERCURY POISONING BY BAL. J Clin Invest (1946) 4.35
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child (1991) 3.29
Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care (2001) 3.09
Does television viewing increase obesity and reduce physical activity? Cross-sectional and longitudinal analyses among adolescent girls. Pediatrics (1993) 3.04
Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr (1992) 2.93
Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci U S A (2000) 2.90
Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79
Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med (2000) 2.76
Weight concerns influence the development of eating disorders: a 4-year prospective study. J Consult Clin Psychol (1996) 2.76
CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL. J Clin Invest (1946) 2.73
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob Agents Chemother (1996) 2.72
Pursuit of thinness and onset of eating disorder symptoms in a community sample of adolescent girls: a three-year prospective analysis. Int J Eat Disord (1994) 2.49
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Educational video game for juvenile diabetes: results of a controlled trial. Med Inform (Lond) (1997) 2.12
Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway. Proc Natl Acad Sci U S A (1997) 2.12
ACUTE VASCULAR LESIONS IN MICE FOLLOWING INJECTIONS OF PNEUMOCOCCI. J Exp Med (1912) 1.98
Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia (2009) 1.92
The RAD2 domain of human exonuclease 1 exhibits 5' to 3' exonuclease and flap structure-specific endonuclease activities. J Biol Chem (1999) 1.91
CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J Clin Invest (1998) 1.87
Semi-automated entry of clinical temporal-abstraction knowledge. J Am Med Inform Assoc (1999) 1.81
An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b. Nature (2009) 1.79
Ethnicity and body dissatisfaction: are Hispanic and Asian girls at increased risk for eating disorders? J Adolesc Health (1996) 1.78
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care (1999) 1.74
3'-phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends. Nucleic Acids Res (1997) 1.72
Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem (2001) 1.67
Patulin production in apples decayed by Penicillium expansum. Appl Microbiol (1973) 1.64
Protonmotive force as the source of energy for adenosine 5'-triphosphate synthesis in Escherichia coli. J Bacteriol (1976) 1.62
Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab (1982) 1.59
A STUDY OF THE RESIDUAL EFFECTS OF PHOSGENE POISONING IN HUMAN SUBJECTS. I. AFTER ACUTE EXPOSURE. J Clin Invest (1947) 1.56
Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr (1984) 1.55
Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. J Lab Clin Med (1999) 1.55
Elements in abasic site recognition by the major human and Escherichia coli apurinic/apyrimidinic endonucleases. Nucleic Acids Res (1998) 1.52
Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty. J Pediatr (1995) 1.52
Glucose-dependent insulin release from genetically engineered K cells. Science (2000) 1.52
Two divalent metal ions in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1: implications for the catalytic mechanism. J Mol Biol (2001) 1.51
Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res (2000) 1.50
Patients' perspectives of a physician-delivered smoking cessation intervention. Am J Prev Med (1991) 1.45
Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1993) 1.45
Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci (2009) 1.44
Knowledge reuse: temporal-abstraction mechanisms for the assessment of children's growth. Proc Annu Symp Comput Appl Med Care (1993) 1.40
Fungus infection in steroid-treated systemic lupus erythematosus. JAMA (1968) 1.39
Validity of measurements of calcium absorption. Pediatr Nephrol (1995) 1.39
Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol (1998) 1.37
The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis (1988) 1.36
Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med (1994) 1.36
The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int (1988) 1.34
Mycotoxins produced by Aspergillus fumigatus species isolated from molded silage. J Agric Food Chem (1977) 1.34
Mapping the protein-DNA interface and the metal-binding site of the major human apurinic/apyrimidinic endonuclease. J Mol Biol (2000) 1.33
Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol (1998) 1.30
First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr (2001) 1.29
Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nat Biotechnol (2000) 1.29
Normal renal function: CIN and CPAH in healthy donors before and after nephrectomy. Mayo Clin Proc (1976) 1.28
Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation of rat adipocytes. J Biol Chem (2000) 1.28
Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.27
Inhibition of growth of Escherichia coli by lactose and other galactosides. Biochim Biophys Acta (1981) 1.27
Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf) (1995) 1.26
Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein. Proc Natl Acad Sci U S A (1999) 1.26
Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr (1995) 1.26
Psychiatric risk associated with early puberty in adolescent girls. J Am Acad Child Adolesc Psychiatry (1997) 1.25
Clinical features and management of cystinuria. Mayo Clin Proc (1977) 1.25
Second human protein with homology to the Escherichia coli abasic endonuclease exonuclease III. Environ Mol Mutagen (2000) 1.24
Prospective study of risk factors for the initiation of cigarette smoking. J Consult Clin Psychol (1997) 1.21
Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes. Diabetes Care (1999) 1.21
Extraction, cleanup, and quantitative determination of aflatoxins in corn. J Assoc Off Anal Chem (1980) 1.20
Hydrochlorothiazide effects on serum calcim and immunoreactive parathyroid hormone concentrations. Studies in normal subjects. Ann Intern Med (1972) 1.18
Assessment and treatment of problem behavior maintained by escape from attention and access to tangible items. J Appl Behav Anal (2001) 1.18
Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int (1998) 1.17
Characterization of the functional interaction of adipocyte lipid-binding protein with hormone-sensitive lipase. J Biol Chem (2001) 1.17
Influence of modified atmosphere storage on aflatoxin production in high moisture corn. Appl Microbiol (1975) 1.16
Blood pressure determinants in living-related renal allograft donors and their recipients. Kidney Int (1987) 1.15
Insect walking. Annu Rev Entomol (1966) 1.14
The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol (1983) 1.14
Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat Biotechnol (1997) 1.13
Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. J Clin Invest (1981) 1.13
Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int (2001) 1.13
Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J (2001) 1.12
Effect of protoporphyrin on hemoglobin synthesis. Biochim Biophys Acta (1965) 1.12
New insights into the structure of abasic DNA from molecular dynamics simulations. Nucleic Acids Res (2000) 1.11
Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab (1983) 1.11
An attempt to modify unhealthful eating attitudes and weight regulation practices of young adolescent girls. Int J Eat Disord (1993) 1.11
Retinyl ester hydrolysis and retinol efflux from BFC-1beta adipocytes. J Biol Chem (1997) 1.10
Insulin-mediated increase in blood flow is impaired in the elderly. J Clin Endocrinol Metab (1995) 1.10
Renin-secreting Wilms' tumor with severe hypertension. Report of a case and brief review of renin-secreting tumors. Ann Intern Med (1973) 1.09
Neuro-muscular control of dipteran flight. J Exp Biol (1967) 1.09
Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. J Biol Chem (1987) 1.09
A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS). Diabetologia (2009) 1.08
Effect of metal binding on the conformation of enterobactin. A proton and carbon-13 nuclear magnetic resonance study. Biochemistry (1973) 1.08
Factors associated with eating disorder symptoms in a community sample of 6th and 7th grade girls. Int J Eat Disord (1994) 1.08
Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk. Hum Exp Toxicol (2012) 1.07
Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum Pathol (1997) 1.05
Studies of macromolecular structure by 13 C nuclear magnetic resonance. II. A specific labeling approach to the study of histidine residues in proteins. J Am Chem Soc (1973) 1.05
Aflatoxin contamination of preharvest corn as influenced by timing and method of inoculation. Appl Environ Microbiol (1981) 1.05
Big renin: a possible prohormone in kidney and plasma of a patient with Wilm's tumor. J Clin Endocrinol Metab (1974) 1.05
Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr (1986) 1.04
Milk-alkali syndrome in patients treated with calcium carbonate after cardiac transplantation. Arch Intern Med (1986) 1.04
Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. J Clin Invest (1970) 1.04
The risks of unilateral nephrectomy: status of kidney donors 10 to 20 years postoperatively. Mayo Clin Proc (1985) 1.03
Regulation of hormone-sensitive lipase during fasting. Am J Physiol (1994) 1.02